FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 317:991-996 October 15, 1987 Number 16 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Protein C deficiency has been thought to be associated with an increased risk of venous thrombosis. To establish a normal range of values, we used a two-site monoclonal-antibody assay to measure protein C levels in 699 healthy adults. The distribution was log normal; 95 percent of the values ranged from 70 to 140 percent of the overall mean (4.03 micrograms per milliliter). Two subjects had levels more than 3.5 SD below the mean (34 and 50 percent), consistent with heterozygous deficiency. We also screened 4723 other blood donors and found 8 additional unrelated subjects with levels from 33 to 51 percent of normal. Autosomal inheritance of heterozygous protein C deficiency was confirmed in them by a detailed study of four families. Levels from 55 to 65 percent of normal are consistent with either heterozygous deficiency or the lower end of the distribution of normal values, and were found in 79 of 5422 subjects when the two groups were combined. None of the subjects had any history of venous thrombosis. We conclude that heterozygous deficiency of protein C has a prevalence of 1 in 200 to 300, a figure consistent with the known number of homozygous infants recently identified, and that levels consistent with heterozygous deficiency are found in 1 in 60 healthy adults but are not detectably associated with a risk of thrombosis.

Source Information

Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110.

This article has been cited by other articles:

• Hasstedt, S. J., Bezemer, I. D., Callas, P. W., Vossen, C. Y., Trotman, W., Hebbel, R. P., Demers, C., Rosendaal, F. R., Bovill, E. G. (2009). Cell adhesion molecule 1: a novel risk factor for venous thrombosis. Blood 114: 3084-3091 [Abstract] [Full Text]  
• Bezemer, I. D., van der Meer, F. J. M., Eikenboom, J. C. J., Rosendaal, F. R., Doggen, C. J. M. (2009). The Value of Family History as a Risk Indicator for Venous Thrombosis. Arch Intern Med 169: 610-615 [Abstract] [Full Text]  
• Dahlback, B. (2008). Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood 112: 19-27 [Abstract] [Full Text]  
• Bezemer, I. D., Bare, L. A., Doggen, C. J. M., Arellano, A. R., Tong, C., Rowland, C. M., Catanese, J., Young, B. A., Reitsma, P. H., Devlin, J. J., Rosendaal, F. R. (2008). Gene Variants Associated With Deep Vein Thrombosis. JAMA 299: 1306-1314 [Abstract] [Full Text]  
• Stone, M. E., Silverman, S. H., Nomoto, K. (2007). Intracardiac Thrombosis and Acute Right Ventricular Failure Following Complex Reoperative Cardiac Surgery With Aprotinin and Deep Hypothermic Circulatory Arrest. SEMIN CARDIOTHORAC VASC ANESTH 11: 177-184 [Abstract]  
• Morozowich, S. T., Donahue, B. S., Welsby, I. J. (2006). Genetics of coagulation: considerations for cardiac surgery.. SEMIN CARDIOTHORAC VASC ANESTH 10: 297-313 [Abstract]  
• Monagle, P., Chan, A., Massicotte, P., Chalmers, E., Michelson, A. D. (2004). Antithrombotic Therapy in Children*: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 645S-687S [Abstract] [Full Text]  
• McBane, R. D. II (2003). Genetically Determined Procoagulant States and Heparin Use. SEMIN CARDIOTHORAC VASC ANESTH 7: 427-442 [Abstract]  
• Deitcher, S. R, Gomes, M. P. (2003). Hypercoagulable state testing and malignancy screening following venous thromboembolic events. Vasc Med 8: 33-46 [Abstract]  
• Tiong, I Y, Alkotob, M L, Ghaffari, S (2003). Protein C deficiency manifesting as an acute myocardial infarction and ischaemic stroke. Heart 89: e7-7 [Abstract] [Full Text]  
• Ohata, T., Sakakibara, T., Takano, H., Ishizaka, T. (2002). Acute Thrombotic Obstruction of Mitral Valve Prosthesis: Low Protein C Level. Asian Cardiovasc. Thorac. Ann. 10: 165-166 [Abstract] [Full Text]  
• Folsom, A. R., Aleksic, N., Wang, L., Cushman, M., Wu, K. K., White, R. H. (2002). Protein C, Antithrombin, and Venous Thromboembolism Incidence: A Prospective Population-Based Study. Arterioscler. Thromb. Vasc. Bio. 22: 1018-1022 [Abstract] [Full Text]  
• Ninomiya, M., Makuuchi, H., Ohtsuka, T., Takamoto, S. (2001). Ischemic heart disease associated with protein C deficiency. Eur. J. Cardiothorac. Surg. 20: 883-885 [Abstract] [Full Text]  
• Seligsohn, U., Lubetsky, A. (2001). Genetic Susceptibility to Venous Thrombosis. NEJM 344: 1222-1231 [Full Text]  
• Ghosh, K., Shetty, S., Madkaikar, M., Pawar, A., Nair, S., Khare, A., Pathare, A., Jijina, F., Mohanty, D. (2001). Venous Thromboembolism in Young Patients From Western India: A Study. CLIN APPL THROMB HEMOST 7: 158-165 [Abstract]  
• Monagle, P., Michelson, A. D., Bovill, E., Andrew, M. (2001). Antithrombotic Therapy in Children. Chest 119 : 344S-370S [Full Text]  
• Kunz, G., Ireland, H. A., Stubbs, P. J., Kahan, M., Coulton, G. C., Lane, D. A. (2000). Identification and characterization of a thrombomodulin gene mutation coding for an elongated protein with reduced expression in a kindred with myocardial infarction. Blood 95: 569-576 [Abstract] [Full Text]  
• Smirnov, M. D., Safa, O., Esmon, N. L., Esmon, C. T. (1999). Inhibition of Activated Protein C Anticoagulant Activity by Prothrombin. Blood 94: 3839-3846 [Abstract] [Full Text]  
• Butenas, S., van't Veer, C., Mann, K. G. (1999). "Normal" Thrombin Generation. Blood 94: 2169-2178 [Abstract] [Full Text]  
• Bucciarelli, P., Rosendaal, F. R., Tripodi, A., Mannucci, P. M., De Stefano, V., Palareti, G., Finazzi, G., Baudo, F., Quintavalla, R. (1999). Risk of Venous Thromboembolism and Clinical Manifestations in Carriers of Antithrombin, Protein C, Protein S Deficiency, or Activated Protein C Resistance : A Multicenter Collaborative Family Study. Arterioscler. Thromb. Vasc. Bio. 19: 1026-1033 [Abstract] [Full Text]  
• Coumans, A.B.C., Huijgens, P.C., Jakobs, C., Schats, R., de Vries, J.I.P., van Pampus, M.G., Dekker, G.A. (1999). Haemostatic and metabolic abnormalities in women with unexplained recurrent abortion. Hum Reprod 14: 211-214 [Abstract] [Full Text]  
• MURIN, S., MARELICH, G. P., ARROLIGA, A. C., MATTHAY, R. A. (1998). Hereditary Thrombophilia and Venous Thromboembolism. Am. J. Respir. Crit. Care Med. 158: 1369-1373 [Abstract] [Full Text]  
• Lefebvre, P., Lierneux, B., Lenaerts, L., Van Maldergem, L., Marecaux, G., Daune, M., Bruninx, G., Delcour, C., Wautrecht, J.-C. (1998). Cerebral Venous Thrombosis and Procoagulant Factors: A Case Study. ANGIOLOGY 49: 563-571 [Abstract]  
• Burdick, C. O., Bertina, R. M. (1998). Thrombotic Risks: A Clarification. Clin. Chem. 44: 1580-1580 [Full Text]  
• Fukudome, K., Ye, X., Tsuneyoshi, N., Tokunaga, O., Sugawara, K., Mizokami, H., Kimoto, M. (1998). Activation Mechanism of Anticoagulant Protein C in Large Blood Vessels Involving the Endothelial Cell Protein C Receptor. JEM 187: 1029-1035 [Abstract] [Full Text]  
• Mac Hale, J. L., Nathan, N., D'Ambra, M. (1997). Intrinsic Anticoagulation: Protein C, Protein S, and Thrombomodulin. SEMIN CARDIOTHORAC VASC ANESTH 1: 319-332 [Abstract]  
• van den Belt, A. G. M., Prins, M. H., Huisman, M. V., Hirsh, J. (1996). Familial Thrombophilia: A Review Analysis. CLIN APPL THROMB HEMOST 2: 227-236 [Abstract]  
• Petaja, J., Lundstrom, U., Sairanen, H., Marttinen, E., Griffin, J. H. (1996). CENTRAL VENOUS THROMBOSIS AFTER CARDIAC OPERATIONS IN CHILDREN. J. Thorac. Cardiovasc. Surg. 112: 883-889 [Abstract] [Full Text]  
• GLUECK, C. J., CRAWFORD, A., ROY, D., FREIBERG, R., GLUECK, H., STROOP, D. (1996). Association of Antithrombotic Factor Deficiencies and Hypofibrinolysis with Legg-Perthes Disease. JBJS 78: 3-13 [Abstract] [Full Text]  
• Kalafatis, M., Lu, D., Bertina, R. M., Long, G. L., Mann, K. G. (1995). Biochemical Prototype for Familial Thrombosis : A Study Combining a Functional Protein C Mutation and Factor V Leiden. Arterioscler. Thromb. Vasc. Bio. 15: 2181-2187 [Abstract] [Full Text]  
• Doig, R. G., Begley, C. G., McGrath, K. M. (1995). Hereditary Protein C Deficiency: The Australian Experience. CLIN APPL THROMB HEMOST 1: 49-54 [Abstract]  
• Roujeau, J. C., Stern, R. S. (1994). Severe Adverse Cutaneous Reactions to Drugs. NEJM 331: 1272-1285 [Full Text]  
• Bauer, K. A. (1993). Coumarin-Induced Skin Necrosis. Arch Dermatol 129: 766-768 [Abstract]  
• Baccard, M., Vignon-Pennamen, M. D., Janier, M., Scrobohaci, M. L., Dubertret, L. (1992). Livedo Vasculitis With Protein C System Deficiency. Arch Dermatol 128: 1410-1411 [Abstract]  
• Falanga, V., Bontempo, F. A., Eaglstein, W. H. (1990). Protein C and Protein S Plasma Levels in Patients With Lipodermatosclerosis and Venous Ulceration. Arch Dermatol 126: 1195-1197 [Abstract]  
• Rick, M. E. (1990). Protein C and Protein S: Vitamin K--Dependent Inhibitors of Blood Coagulation. JAMA 263: 701-703 [Abstract]  
• Dominey, A., Kettler, A., Yiannias, J., Tschen, J. A. (1988). Purpura Fulminans and Transient Protein C and S Deficiency. Arch Dermatol 124: 1442-1443 [Abstract]